Low-dose radiotherapy for lung inflammation in severe COVID-19November 5, 2020COVID-19 UpdatesPatient & Survivor Care
‘Tour de force’ study reveals therapeutic targets in 38% of cancer patientsOctober 27, 2020Patient & Survivor Care
Are oncologists ready to confront a second wave of COVID-19?October 21, 2020COVID-19 UpdatesPatient & Survivor Care
Efforts to close the ‘AYA gap’ in lymphomaOctober 20, 2020B Cell LymphomaHodgkin LymphomaPatient & Survivor Care
Cancer researchers cross over to COVID-19 clinical trialsOctober 20, 2020Patient & Survivor CareCOVID-19 Updates
Clinical factors and treatment tied to COVID-19 mortality in cancer patientsOctober 8, 2020Patient & Survivor CareCOVID-19 Updates
The scope of under- and overtreatment in older adults with cancerOctober 1, 2020Patient & Survivor Care
COVID-19 prompts ‘democratization’ of cancer trialsSeptember 16, 2020COVID-19 UpdatesPatient & Survivor Care
VTE, sepsis risk increased among COVID-19 patients with cancerAugust 31, 2020COVID-19 UpdatesPatient & Survivor Care
Immunotherapy should not be withheld because of sex, age, or PSAugust 27, 2020Patient & Survivor Care
Aspirin may accelerate cancer progression in older adultsAugust 27, 2020Patient & Survivor CareThrombosis
COVID-19 impact: Less chemo, immune checkpoint inhibitors, and steroidsAugust 14, 2020Patient & Survivor CareCOVID-19 Updates
Hepatitis screening now for all patients with cancer on therapyAugust 6, 2020Patient & Survivor CareHodgkin LymphomaIndolent LymphomaMantle Cell LymphomaB Cell LymphomaAggressive Lymphomas
